Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/05 17:48 | 6/2/05 | AGNT | Health | Diagn | In Vitro & In Vivo Diagnostic | Bentovim Lyron L | CA | D | P | 538 | 0.9684 | 0 | 556 | 20 | 3,294 | I | |||||||||||||||
12/3/03 14:29 | 12/2/03 | AGNT | Health | Diagn | In Vitro & In Vivo Diagnostic | Goldstein Howard | CA | O | SVP,Sale | P.d | 7 | 1.39 | 0 | 5 | 33 | 20 | D | ||||||||||||||
11/10/03 20:06 | 11/7/03 | AGNT | Health | Diagn | In Vitro & In Vivo Diagnostic | Foster David J | CA | O | CFO | P.d | 12 | 1.20 | 0 | 10 | 200 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |